Clinical trial

STIMPulseControl Ancillary Speech Study

NCT06561919

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-09-05

PhaseNA

Study timeline

Study start (actual)2024-09-05Date precision: day

Registry last updated2025-12-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseverified · MONDO: Parkinson disease

Impulse Control Disorderverified · MONDO: impulse control disorder

Interventions

bilateral high frequency deep brain stimulation of the subthalamic neucleus combined with best medical treatment according to widely accepted expert consensus paperPROCEDURE

best medical treatment for management of impulse control in Parkinson´s disease according to widely accepted expert consensus paperDRUG

Sponsors & collaborators

Steffen Paschenlead sponsor

Czech Technical University in Praguecollaborator

Insel Gruppe AG, University Hospital Berncollaborator

Philipps University Marburgcollaborator

University Hospital Schleswig-Holsteincollaborator

Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)collaborator

Mapped research locations

HamburgGermany1 AmsterdamNetherlands1 DresdenGermany1 CologneGermany1 ZurichSwitzerland1 BernSwitzerland1 DüsseldorfGermany1 TübingenGermany1 WürzburgGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06561919 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.